[ET Net News Agency, 29 August 2025] REMEGEN (09995) rose 10.1% to HK$96.85.
It hits an intra-day high of HK$97, hitting a 52-week high, and an intra-day low of
HK$87.5. The total shares traded was 5.02 million, with a value of HK$465.11m. The active
buy/sell ratio is 70:30, with net buying turnover of HK$178.43m. MERRILL LYNCH FE accounts
for greatest net responsive buying turnover of HK$6.18m, with volume weighted average
price of HK$92.141. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$41.02m, with volume weighted average price of HK$92.253. The stock
has risen a combined 10.2% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 96.850 % Chg +10.06%
High 97.000 Low 87.500
Shares Tr 5.02m Turnover 465.11m
10-D SMA 85.645 %H.V 71.165
20-D SMA 76.108 VWAP 92.599
50-D SMA 68.795 RSI14 74.391
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 70:30, with net buying turnover
of HK$178.43m, rising a combined 10.2% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 96.85 +10.06
SINO BIOPHARM (01177) 7.99 +3.90
3SBIO (01530) 28.66 +3.69
EVEREST MED (01952) 66.25 -1.56
WUXI XDC (02268) 56.55 +5.60
ASCENTAGE-B (06855) 82.60 +2.23
SKB BIO-B (06990) 467.60 +3.00
ZAI LAB (09688) 25.54 +1.67
AKESO (09926) 151.30 -0.59
INNOCARE (09969) 17.25 +2.31
---------------------------------------------
(ed)